How were Medidata Solutions' earnings last quarter?

Medidata Solutions Inc (NASDAQ:MDSO) issued its quarterly earnings results on Monday, July, 22nd. The company reported $0.48 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.17 by $0.31. The business had revenue of $180.50 million for the quarter, compared to the consensus estimate of $179.95 million. Medidata Solutions had a trailing twelve-month return on equity of 8.64% and a net margin of 6.43%. The business's quarterly revenue was up 15.8% on a year-over-year basis. During the same period in the prior year, the firm posted $0.43 earnings per share.

What other stocks do shareholders of Medidata Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medidata Solutions investors own include NVIDIA (NVDA) , Applied Materials (AMAT) , Salesforce (CRM) , Gilead Sciences (GILD) , Allergan (AGN) , Alibaba Group (BABA) , Just Eat Takeaway.com (GRUB) , International Business Machines (IBM) , Western Digital (WDC) and BioMarin Pharmaceutical (BMRN) .

NASDAQ:MDSO

Medidata Solutions (MDSO) Stock Price, News & Analysis

→ Could Bitcoin Literally FORCE This Crypto To Rocket Up? (From Paradigm Press) (Ad)

Free MDSO Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $92.21
▼
$92.26
50-Day Range: $91.79
▼
$92.25
52-Week Range: $60.10
▼
$98.60

Volume: 7.30 million shs
Average Volume: 1.24 million shs
Market Capitalization: $5.76 billion

P/E Ratio: 96.06
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Medidata Solutions alerts:

Ad American Alternative

Your Money is Not Safe

Biden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…

CLICK HERE TO GET YOUR GUIDE NOW

About Medidata Solutions Stock (NASDAQ:MDSO)

Medidata Solutions, Inc. provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management. It also provides professional services, such as implementation, sponsor enablement, strategic consulting, partner support, and e-learning and training. The company markets and sells its cloud-based solutions through a direct sales force and through relationships with channel and strategic partners. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; academic research centers, government, and other non-profit organizations; and other non-profit organizations; and contract research organizations and other entities engaged in clinical trials. The company was founded in 1999 and is headquartered in New York, New York.

Ad American Alternative

Your Money is Not Safe

CLICK HERE TO GET YOUR GUIDE NOW

MDSO Stock News Headlines

November 20, 2023 | tmcnet.com

Fortrea Announces AI-Driven Partnership with Medidata to Increase Diversity in Clinical Trials

November 13, 2023 | finance.yahoo.com

George Clinical Partners with Medidata to Unlock Operational Efficiency in Clinical Trials

April 17, 2024 | American Alternative (Ad)

Your Money is Not Safe

November 8, 2023 | msn.com

Medidata and EDETEK partner for clinical data management

November 8, 2023 | businesswire.com

Medidata Announces New Data Integration Solutions to Accelerate Clinical Trials: Clinical Data Studio and Health Record Connect

November 7, 2023 | tmcnet.com

Medidata and EDETEK Announce Partnership to Revolutionize Global Clinical Trial Data Management

November 6, 2023 | finance.yahoo.com

TFS HealthScience Becomes First CRO to Adopt Medidata Detect, Improving Data Sharing Efficiency and Product Development

November 2, 2023 | finance.yahoo.com

Medidata NEXT New York to Unveil New Vision for Life Sciences Innovation

April 17, 2024 | American Alternative (Ad)

Your Money is Not Safe

October 27, 2023 | msn.com

Medidata and Catalyst expand oncology trial collaboration

October 26, 2023 | tmcnet.com

Medidata Announces Expansion of Multi-Year Partnership with Catalyst Clinical Research for Oncology Trials

September 21, 2023 | msn.com

Medidata unveils new solution to boost clinical trial diversity

April 13, 2023 | finance.yahoo.com

PROMETRIKA Achieves Accreditation in Medidata Rave RTSM

April 12, 2023 | finance.yahoo.com

Launch Therapeutics Selects Medidata AI Intelligent Trials to Accelerate Clinical Trial Development

April 3, 2023 | thestreet.com

Advent Soars, Integrated Leaps: Tech Winners & Losers

March 30, 2023 | finance.yahoo.com

Customer Award Winners Unveiled at Medidata NEXT Conference

March 23, 2023 | finance.yahoo.com

Global Medidata Certification Model Helps Rave EDC Study Builders Create New Value for Their Companies

February 6, 2023 | businesswire.com

IDC MarketScape Names Medidata a Leader in Life Science R&D Risk-Based Monitoring Solutions Vendor Assessment

February 3, 2023 | benzinga.com

Medidata Experts Present New Insights on Risk-Based Quality Management, Decentralized Clinical Trials, and Real World Data at SCOPE Summit

December 13, 2022 | finance.yahoo.com

Everest Group Names Medidata a ‘Leader’ and ‘Star Performer’ in Decentralized Clinical Trial Platforms

December 8, 2022 | yahoo.com

Medidata Receives Prestigious Innovation Award from Reagan-Udall Foundation for the FDA

December 6, 2022 | nz.finance.yahoo.com

Medidata Launches New myMedidata Native App to Expedite Study Start Up and Improve Patient Experience

November 22, 2022 | tmcnet.com

Medidata Patient Insights Leader Alicia Staley Honored by National Coalition for Cancer Survivorship

November 15, 2022 | technews.tmcnet.com

Medidata Launches Rave Companion, the First Scalable Solution for Automating EHR Data Entry into Rave EDC

October 27, 2022 | finance.yahoo.com

Boehringer Ingelheim Extends the Use of Medidata Rave for Electronic Data Capture in Clinical Trials

October 27, 2022 | finance.yahoo.com

eClinical Solutions Achieves New Medidata Accreditation Enhancing Digital Services to Support High Quality, Faster Digital Trials at Scale

October 13, 2022 | finance.yahoo.com

New Medidata Technology Helps Sponsors and CROs Improve Diversity and Inclusion in Clinical Trials

See More Headlines

Receive MDSO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medidata Solutions and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 7/22/2019
Today: 4/17/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Prepackaged Software
Sub-Industry: Health Care Technology
Current Symbol: NASDAQ:MDSO
CUSIP: 58471A10
CIK: 1453814
Web: www.mdsol.com
Phone: 212-918-1800
Fax: N/A
Employees: 1,998
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): $0.96
Trailing P/E Ratio: 96.06
Forward P/E Ratio: 118.23
P/E Growth: 6.95
Net Income: $51.92 million
Net Margins: 6.43%
Pretax Margin: N/A
Return on Equity: 8.64%
Return on Assets: 5.73%

Debt

Debt-to-Equity Ratio: 0.27
Current Ratio: 2.56
Quick Ratio: 2.56

Sales & Book Value

Annual Sales: $635.70 million
Price / Sales: 9.06
Cash Flow: $1.69 per share
Price / Cash Flow: 54.55
Book Value: $10.32 per share
Price / Book: 8.94

Miscellaneous

Outstanding Shares: 62,460,000
Free Float: N/A
Market Cap: $5.76 billion
Optionable: Optionable
Beta: 1.22

7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

Mr. Tarek A. Sherif (Age 57)
Co-Founder, Chairman & CEO
Mr. Glen M. de Vries (Age 47)
Co-Founder, Pres & Director
Mr. Rouven Bergmann (Age 46)
Chief Financial Officer
Mr. Michael Pray (Age 53)
Exec. VP - Gen. Mang. of Global Sales
Ms. Jill Larsen (Age 46)
Exec. VP - HR & Chief HR Officer

Key Competitors

View All Competitors

MDSO Stock Analysis - Frequently Asked Questions

How were Medidata Solutions' earnings last quarter?: Medidata Solutions Inc (NASDAQ:MDSO) issued its quarterly earnings results on Monday, July, 22nd. The company reported $0.48 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.17 by $0.31. The business had revenue of $180.50 million for the quarter, compared to the consensus estimate of $179.95 million. Medidata Solutions had a trailing twelve-month return on equity of 8.64% and a net margin of 6.43%. The business's quarterly revenue was up 15.8% on a year-over-year basis. During the same period in the prior year, the firm posted $0.43 earnings per share.
What other stocks do shareholders of Medidata Solutions own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Medidata Solutions investors own include NVIDIA (NVDA), Applied Materials (AMAT), Salesforce (CRM), Gilead Sciences (GILD), Allergan (AGN), Alibaba Group (BABA), Just Eat Takeaway.com (GRUB), International Business Machines (IBM), Western Digital (WDC) and BioMarin Pharmaceutical (BMRN).

This page (NASDAQ:MDSO) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Medidata Solutions (MDSO) Stock Price, News & Analysis

About Medidata Solutions Stock (NASDAQ:MDSO)

MDSO Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

MDSO Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info